Canada markets closed

Aridis Pharmaceuticals, Inc. (ARDS)

OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
Add to watchlist
0.0500-0.0029 (-5.48%)
At close: 02:12PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.67M
Enterprise Value 7.48M
Trailing P/E 2.83
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.13
Price/Book (mrq)5.40
Enterprise Value/Revenue 0.38
Enterprise Value/EBITDA -0.87

Trading Information

Stock Price History

Beta (5Y Monthly) 1.06
52-Week Change 3-77.19%
S&P500 52-Week Change 324.16%
52 Week High 30.3263
52 Week Low 30.0312
50-Day Moving Average 30.0629
200-Day Moving Average 30.0710

Share Statistics

Avg Vol (3 month) 397.66k
Avg Vol (10 day) 3107.83k
Shares Outstanding 544.57M
Implied Shares Outstanding 644.57M
Float 837.29M
% Held by Insiders 118.05%
% Held by Institutions 110.38%
Shares Short (Jun 30, 2023) 42M
Short Ratio (Jun 30, 2023) 40.22
Short % of Float (Jun 30, 2023) 46.80%
Short % of Shares Outstanding (Jun 30, 2023) 45.55%
Shares Short (prior month May 31, 2023) 4439.68k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sept 30, 2023


Profit Margin -5.11%
Operating Margin (ttm)-208.39%

Management Effectiveness

Return on Assets (ttm)-4.40%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)22.36M
Revenue Per Share (ttm)0.69
Quarterly Revenue Growth (yoy)4.50%
Gross Profit (ttm)N/A
EBITDA -347k
Net Income Avi to Common (ttm)-1.14M
Diluted EPS (ttm)-0.1600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)35k
Total Cash Per Share (mrq)0
Total Debt (mrq)4.84M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.23
Book Value Per Share (mrq)-0.26

Cash Flow Statement

Operating Cash Flow (ttm)-17.89M
Levered Free Cash Flow (ttm)-16.39M